Health News Releases

  • Today March 21
December 17, 2024 11:20
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54166940&newsitemid=20241216604376&lan=en-US&anchor=HistoSonics&index=1&md5=035f1602d28e12cb40e
Clinical Trial Management Award for Novotech (Graphic: Business Wire)
December 17, 2024 09:35
Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th
December 15, 2024 14:45
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of patients 12 years and older with moderate
December 15, 2024 13:40
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing
*For research purposes only. (Graphic: Business Wire)
December 15, 2024 13:15
PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
The Biomedical Division of PHC Corporation (https://www.phchd.com/global/phc) (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has received a 2024 Innovation Award from The Analy
December 13, 2024 15:37
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing aut
December 13, 2024 13:35
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
Tanner Pharma, a global provider of specialty medicine access solutions, today announced a collaboration with Agenus, a leading immuno-oncology company, to provide expanded access to botensilimab (BOT
December 13, 2024 11:55
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine at ESMO-IO 2024
PDC*line Pharma, a clinical-stage biotech company developing a new class of immunotherapies for cancers, presented the primary results of its phase I/II clinical trial for PDC*lung01, an innovative of
December 13, 2024 11:45
Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
Octapharma (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.octapharma.ca%2Fen%2F&esheet=54164832&newsitemid=20241211594907&lan=en-US&anchor=Octapharma&index=1&md5=ca5c5d335e96ce
December 13, 2024 11:40
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications
Parse Biosciences, a leader in scalable single cell sequencing solutions, today announced the expansion of its Evercode BCR (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parse
December 13, 2024 09:01
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54165415&newsitemid=20241211148492&lan=en-US&anchor=TSE%3A4502%2FNYSE%
December 12, 2024 15:00
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66
Ultrastructural representation of the BK polyomavirus capsid, featuring 72 pentamers that form its d
December 12, 2024 14:55
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing total funding to over $25M. Thi
December 12, 2024 10:35
SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industries, today announced the launch of a brand uni
December 11, 2024 09:55
Huonslab Announces Successful Enrollment and Administration of First Patient in Phase 1 Pivotal Study for Hydizyme™ (rHuPH20)
Huonslab (https://huonslab.com/layout/eng/home.php?go=main&), a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ: 084110), announced on December 10th the successful enrollment
December 06, 2024 11:20
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54161904&newsitemid=20241205693431&lan=en-US&anchor=Parse+Biosciences&index=1&md
Nurse Maria Victoria Juan from Philippines – Winner of Aster Guardians Global Nursing Award 2024 (Ph
December 05, 2024 13:50
Nurse Maria Victoria Juan From Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024
Nurse Maria Victoria Juan from Philippines, a Consultant at Philippines Army Health Services and Colonel, Reserve Force of the Armed Forces of the Philippines, has been announced as the winner of the
Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)
December 05, 2024 10:45
Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54160539&newsitemid=20241203677092&lan=en-US&anchor=Avania&index=1&md5=4b5f83247ba447bb7edd17
December 04, 2024 10:45
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54160718&newsitemid=20241202182459&lan=en-US&anchor=TSE%3A4502%2FNYSE%
Nihon Medi-Physics headquarters and woman looking at molecular imaging images (Photo: Business Wire)
December 02, 2024 14:15
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own. As part
November 29, 2024 09:23
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with moderate-to-
Portrait of Dr. Martin Steinhart, CEO AOP Health (Photo: AOP Health/Studio Koekart)
November 28, 2024 10:15
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk™ (landiolol) in the hosp
November 27, 2024 16:00
Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) is pushing forward research into cold plasma for the prevention of ventilator-associated pneumonia (VAP). Under the scientific directio
November 24, 2024 11:10
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
Ribbon Cutting of the Lab (Photo: Business Wire)
November 22, 2024 16:40
Rigaku BioScience Lab Opens in USA
Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku
25 per page50 per page75 per page100 per page